Senior author Pauline Pradère, MD, of Hôpital Marie Lannelongue in Paris, joins the episode to talk about the paper.
The conversation includes discussion of:
The overall survival of patients who develop lung cancer after lung transplant—and the key differences between the cohort of patients who developed cancer versus the patients who did not
Managing lung cancer in transplant recipients
Immunosuppression in these patients, and other potential changes to clinical practice derived from the study
Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.
Podden och tillhörande omslagsbild på den här sidan tillhör
ISHLT. Innehållet i podden är skapat av ISHLT och inte av,
eller tillsammans med, Poddtoppen.